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Background: Few studies have assessed placental malaria infections from low transmission areas by histopathology
to define their impact and underlying mechanisms.
Methods: Peripheral smears and rapid diagnostic tests (RDTs), placental smears and histological samples, birth
weight and gestational age were collected from 2,282 deliveries in three hospitals during a one-year (2006–2007)
continuous cross-sectional survey in Madhya Pradesh. Placental histopathology included all 50 cases positive by
microscopy or RDT plus 456 randomly selected samples of women negative for malaria by microscopy or RDT.
Histological examination included parasites, inflammatory cells, pigment in fibrin, and morphological changes.
Results: There were 52 histology-positive cases; 38 (73.1%) active (acute and chronic) and 14 past infections. Intervillous
parasitaemia was low (60% had < 1% parasitaemia) and monocytosis mostly mild (63%). Compared with uninfected
placentas, acute Plasmodium falciparum infections were associated with stillbirth (RR 3.8, 95% CI 1.2-12.1), lower
maternal haemoglobin (mean difference: 1.5 g/dL, 95% CI 0.5-2.5), lower birth weight (mean difference 451 g, 95% CI
169–609) and shorter gestation (mean difference 0.8 weeks, 95% CI 0.2-1.4). Chronic or past infections were not
associated with these outcomes. Among the 11 peripheral Plasmodium vivax cases, placental parasites were absent, but
they were associated with increased placental polymorphonuclear cells.
Conclusions: Malaria associated stillbirth and low birth weight in women with low protective immunity may result, at
least in part, from a shortened gestation triggered by acute infection, stressing the importance of early malaria
detection.
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An estimated 125 million pregnant women worldwide
are exposed to the risks of malaria in pregnancy (MiP)
every year, contributing to morbidity and mortality in
pregnant women and newborn babies [1,2]. The pathology
is related to placental sequestration due to cytoadhesion
of P. falciparum infected erythrocytes to the placental gly-
cosaminoglycan chondroitin sulphate A receptors and as-
sociated inflammatory responses. The resulting features of* Correspondence: D.J.Terlouw@liverpool.ac.uk
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unless otherwise stated.parasite sequestration, increased presence of inflammatory
cells, deposition of pigment (haemozoin), and fibrin char-
acterize placental malaria and have been used to classify
the chronology of placental infections [3,4]. The associ-
ation between histologic grades of infection in P. falcip-
arum infected placentas and low birth weight and
maternal anaemia is well documented in high malaria en-
demic African regions [5-8], with reports of dense parasit-
aemia and occasional massive chronic intervillositis and
monocyte infiltration mainly, but not exclusively from
Africa [9,10]. This led to suggestions that the accumula-
tion of parasites per se, with the corresponding inflamma-
tory response to the sequestered parasites is associated
with fetal growth restriction [11-13].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tion whether the same holds for those regions. In these
areas, a detrimental impact has been observed with rela-
tively low-grade and early-pregnancy peripheral P. fal-
ciparum and P. vivax infections and placental malaria
described in Colombia [14-18]. Severe manifestations of
P. vivax infection have been associated with pronounced
maternal anaemia and cytokine-mediated inflammatory
response [19]. Low-grade P. vivax infections have been
associated with intrauterine growth restriction [20], and
an increased risk of miscarriage and low birth weight
[21]. These findings stress the limited understanding of
the population burden in areas outside Africa, and have
led to recent calls for more area and species specific in-
formation to guide control strategies for these highly di-
verse malaria endemic regions [21].
Comprehensive, reproducible histopathology studies
can help elucidate the placental changes and mecha-
nisms that occur with P. falciparum and P. vivax infec-
tions in areas of low transmission. P. vivax was not
considered to sequester in the microcirculation, until in-
vitro studies recently showed that (a fraction of) P. vivax
infected erythrocytes do have the potential to cytoadhere
to the placental syncytiotrophoblast glycosaminoglycans
chondroitin sulphate A responsible for P. falciparum se-
questration in the placenta [22,23]. While this suggests a
comparable pathogenesis to P. falciparum, the occur-
rence and extent of sequestration in vivo has not been
shown. Three other studies recently reported histopath-
ology findings of Plasmodium infections in Asia and
Latin America [24-26], but overall the number of cases
examined remain low (n = 24, 19, and 78 respectively).
It is not clear how the morphological changes in the pla-
centa described for placental malaria mainly in Africa
[7,9] relate to the commonly used histological grading
system for placental malaria [3,4], to other malaria test
results and to adverse birth outcome in a low transmis-
sion setting [10].
Methods
Study location
The study sites were in three districts in Madhya Pradesh,
central India. Malaria transmission in this region is highly
seasonal and P. falciparum and P. vivax co-exist. In the
underlying burden surveys we conducted the overall ma-
ternal malaria prevalence was 1.8% among 2282 women
recruited at the time of delivery (0.8% in the dry season
and 3.3% in post rainy season). Based on standard micros-
copy, the prevalence of placental malaria was 1.0%; 0.5%
in the dry season and 2.1% in the post rainy season. P. fal-
ciparum was the predominant species in 72.5% of the ob-
served maternal and 87.0% of placental infections.
According to a previous survey in Madhya Pradesh in
2007–8, 61% of pregnant women visited ANC at leastonce and 34% at least three times, whereas 47.1% of
women had institutional deliveries [27]. The national
malaria guidelines at the time of the study recom-
mended parasitological diagnosis with either microscopy
or a rapid diagnostic malaria test (RDT) for all clinically
suspected cases of malaria in pregnancy (case manage-
ment), and treatment of uncomplicated P. vivax cases in
pregnancy with chloroquine for three days, and uncom-
plicated P. falciparum cases with artesunate for three
days in combination with single dose sulphadoxine-
pyrimethamine on day 1. Quinine was the drug of choice
for first trimester treatment of P. falciparum. All preg-
nant women with anaemia (haemoglobin [Hb] <11 g/dL)
were given haematinic supplementation (usually Fefol
tablets: a combination of 150 mg ferrous sulphate and
0.5 mg folic acid) in the antenatal clinics. Although at
the time of the study weekly chloroquine prophylaxis
was recommended, this was not implemented in the par-
ticipating hospitals.
Procedures
Surveys were conducted in the delivery units in a hos-
pital in Jabalpur city between September and October
2006 and in hospitals in the towns of Katni (semi-rural)
and Maihar (rural) between October 2006 and September
2007 to assess the burden of MiP. Information on demo-
graphic parameters, reproductive and malaria morbidity
and prevention history during pregnancy, and delivery
outcome were obtained. Newborns were weighed to the
nearest 10 grams within two hours of delivery on a
digital scale (Sansun, Sansui Electronics Pvt Ltd, India).
Scales were calibrated weekly with a standard 5 kg
weight. Gestational age was assessed within 24 hours of
delivery using the Ballard score by staff trained by and
under weekly supervision of the study paediatrician
[28]. A maternal finger prick blood sample was collected
during labour for malaria microscopy, pLDH-based
rapid diagnostic test (RDT) (First Response Pf/Pv® from
Premier Medical Corporation Ltd, Mumbai, India) and
haemoglobin measurement (HemoCue® B-Hemoglobin,
Angelholm, Sweden). All women with peripheral parasit-
aemia detected by microscopy or RDT were referred to
the clinicians for appropriate treatment. Within three
hours of delivery, placental incision and impression
smears for microscopy and placental blood for PCR were
taken. In addition, two 2 x 2 x 1cm biopsies for histopath-
ology were taken from the maternal side of the placenta at
opposite sites half-way between the umbilical cord inser-
tion and the placental edge and fixed in 10% phosphate
buffered formalin. Fixed tissues were trimmed to 3 mm
sections, placed in cassettes and fresh buffered formalin
and stored in an air-conditioned room with the fixative
changed monthly to ensure pH stability. Specimens were
embedded in paraffin wax within 3 months using standard
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(two sections per placenta) and processed and stained with
haematoxylin and eosin at the National Institute for
Malaria Research (NIMR) field laboratory in Jabalpur,
India.
Histology slides were examined locally under standard
and polarized light microscopy to increase the sensitivity
of haemozoin detection [29]. The reviewer (RA) was
aware of the blood smear results, but unaware of the
maternal characteristics, obstetric history and pregnancy
outcome of the examined cases. Slides were examined
under 40x, or 100x magnification for the presence of
parasites and inflammatory cells and scored semi-
quantitatively in any of the 50 fields examined. The scor-
ing system used is presented in the Table 1. Based on
histopathology, cases with parasites were classified as ac-
tive infections, consisting of chronic infections (parasites
plus haemozoin in monocytes and/or fibrin) and acute
infection parasites and +/− pigmented monocytes with
few spots or no pigmented fibrin [3,4]. Cases with pig-
ment in fibrin in the absence of parasites were classified
as past infections. Percentage parasitized erythrocytes
was calculated against 500 maternal erythrocytes per
high power (HPF, 100x magnification) and classified <
1% parasitaemia if 1–5 infected erythrocytes per HPF
was observed (scanty), 1-10% in moderate infection
and > 10% parasitaemia when >10 infected erythrocytes
was observed in 2 or more HPF (Table 1). When there
was less than 500 erythrocytes per HPF the formula used
was number of parasitized erythrocytes multiplied by
100/number of maternal erythrocytes present per HPF.Table 1 Scoring system used to evaluate presence and severi
Histopathologic severity
Mild
Perivillous or intervillous fibrin Present in <20% IVS
Fibrinoid necrosis Focal: localised to few fibrin areas
Calcification Focal: localised to few areas
of fields viewed
Syncytial knots Normal: <1/3 villi affected
Pigment deposition Focal presence in small amounts
Polymorphonuclear cells <10 cells/HPF
Mononuclear cells <10 cells/HPF
Parasite presence* Scanty: 1-5/in any HPF
Parasitaemia** 1%
Note: Intervillous spaces and villous structures were examined for the presence of par
inflammatory cells, villous stroma, the syncytium and Hofbauer cells were examined fo
syncytial knots, Hofbauer cells, foetal red blood cells, villous stroma and fibrinoid necro
material that shows birefringence under polarized light. Calcifications were identified a
*Plasmodium species can not be identified on histology slides, and is based on the
against 500 erythrocytes per HPF.
Abbreviations: IVS intervillous space, HPF High power field (100x), (total fields viewePCR of placental blood was performed for species con-
firmation in all the 52 histology positive cases, and for
an additional 63 negative cases matched for site and gra-
vidity, selected for quality assurance for a malaria diagno-
sis sub-study. Placental red blood cell pellets produced at
the time of placental sampling from 250-500 μL blood
and stored at −20°C were analysed. Nested PCR was used
for genus and species specific analysis of P. falciparum
and P. vivax; PCR analysis was carried out at the NIMR
field station laboratory in Jabalpur [30]. The primary reac-
tion was conducted on a volume of 25 μL consisting of 5
μL DNA. Species amplification was performed on aliquot
of 2 μL in 1:10 dilution of first reaction mixture.
Definitions
Subpatent infections were defined as active infections
detected by histopathology which were negative by any
standard peripheral and placental microscopy and per-
ipheral RDT. A low birth weight was defined as a birth
weight <2,500 grams among singleton deliveries. Prema-
turity was defined as a new born delivered before the
gestational age of 37 weeks among singletons as defined
by the Ballard score. Fever at the time of delivery was de-
fined as documented fever with an axillary temperature of
≥37.5°C, or a history of fever in the past 24 hours at the
time of delivery.
Sample size
Because of costs and labour limitations, not all placental
histology samples could be processed. A sub-sample of
506 from 2,282 participants was selected for placentalty of placental pathologic changes and parasitaemia
Moderate Severe
Present in 20-50% IVS Present in >50% IVS
Diffuse: >50% fibrin affected
Diffuse: >50% affected in
total fields viewed
>1/3 villi affected in total
fields viewed
Small spots or larger de- posits
in many locations
Large amount present widely
10-25 cells/HPF >25cells /HPF
10-25 cells/HPF >25 cells/HPF
5-10 in 2 or more HPF >10 in any 2 or more HPF
1-10% >10%
asitized cells and inflammatory cells. The intervillous and perivillous fibrin,
r the presence of pigment deposition. Morphological changes were evaluated in
sis and calcification. Pigment was identified as brownish granular looking
s dark bluish purple spots that did not show birefringence on polarized light.
standard microscopy and RDT results. **Percent parasitaemia is calculated
d = 50), RDT rapid diagnostic tests.
Table 2 Participant characteristics
Parameters N = 506
Age in years, mean (SD) 23.8 (3.4)
Age categories
<20 yr, n (%) 10 (1.9)
20-29 yr, n (%) 454 (89.9)
≥30 yr, n (%) 41 (8.1)
Residence
Urban, n (%) 148 (29.2)
Rural, n (%) 359 (70.8)
Education
No schooling, n (%) 161 (31.8)
Primary, n (%) 136 (26.8)
Secondary, n (%) 173 (34.2)
Higher, n (%) 36 (7.1)
SES1 rank (quintiles) n (%)
1 – Poorest 117 (23.1)
2 107 (21.2)
3 112 (22.1)
4 85 (16.8)
5 85 (16.8)
Gravidity
Primigravidae, n (%) 216 (42.7)
Secundigravidae, n (%) 162 (32.0)
Gravidae-3, n (%) 73 (14.4)
Gravidae-4, n (%) 34 (6.7)
Multigravidae (≥5)2 n (%) 21 (4.2)
Used bednet previous night, n (%) 89 (17.8)
ITN (any), n (%) 1 (0.2)
Used any drug to prevent malaria, n (%) 4 (0.8)
Reported using haematinics, n (%) 427 (84.7)
Morbidity and Outcomes
Reported fever previous week, n (%) 82 (16.2)
Used antimalarial for fever, n (%) 10 (1.9)
Maternal fever at delivery3, n (%) 35 (6.9)
Birth weight± (g), mean (SD) 2621 (450)
Birth weight <2500 g, n (%) 176 (37.1)
Baby’s gestational age in weeks4, mean, (SD) 37.2 (1.3)
Preterm babies <37 weeks), n (%) 95 (20.0)
Stillbirths≠, n (%) 22 (4.4)
Stillbirths in uninfected women, n (%) 18 (3.6)
Maternal Hb (g/dL), mean (SD) 10.5 (2.2)
1SES = socioeconomic status (based on underlying survey population);
2= pregnancy number.
3= Fever = axillary temperature ≥ 37.5°C; 4= assessed by Ballard score; ±Birth
weight and gestational age data was available for 474 babies out of 482
singleton live births; data for 2 babies are missing out of the 506 samples;
≠Stillbirth denominator = 504.
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total sample) at delivery determined by microscopy or
RDT on either peripheral, or placental smear (incision
or impression smear). The remaining 456 samples were
randomly selected from the remaining 2,232 smear/RDT
negative women stratified by site. For every woman with
a patent infection (smear or RDT positive) at least one
additional infection was assumed to be detected by hist-
ology (active or past infection). A sample size of 456
smear/RDT negative cases allowed us to detect a preva-
lence of sub-patent infections of ≤3% with an absolute
precision of ±3% at a 95% confidence level.
Statistical analysis
Data was analysed using SAS® 9.1 (Statistical Application
Software, SAS Institute Inc. Cary NC). Placental changes
corresponding to infection categories were evaluated
using the χ2 test. To assess the impact of infection on
birth outcomes, univariate analyses were performed
using Student’s t test or analysis of variance (ANOVA)
for continuous endpoints. Multivariate analyses were
performed using General Linear Models (GLM) with
birth weight, gestational age and haemoglobin as the
continuous dependent variables and histology graded in-
fection status (acute, chronic, past or no infection) as
the independent predictor of interest. Additional models
assessed the association between these endpoints and
the individual or combination of histological parameters
(parasites, syncytial knots, fibrinoid necrosis, calcifica-
tion, intervillous space polymorphonuclear cells, intervil-
lous space monocytes, intervillous space fibrin). The
socio-demographic parameters; socioeconomic status,
education, residence and gravidity were included in all
initial models as co-variates. A significance level of P =
0.05 was used to retain independent predictors in the
model and 95% confidence intervals were calculated
using Tukey’s multiple comparison test.
Ethical approval
The study was approved by the Research Ethical Com-
mittees of the National Institute of Malaria Research
Delhi, Indian Council of Medical Research in India,
CDC in U.S.A, and the Liverpool School of Tropical
Medicine (LSTM) in the UK. All the study participants
provided written informed consent.
Results
The mean age of women was 23.8 (3.4) years and there
were 42.7% primigravidae (Table 2). The proportion of
women reporting use of bed net the previous night was
17.8%. A documented fever (≥37.50C) was present in
6.9% women and 16.2% reported fever previous week,
whereas only 1.9% used anti-malarial for fever. Low birth
weight was 37% and 20.8% was preterm births. In total
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in women with placental malaria.
Malaria infection based on histopathology
Placental malaria was identified in 52 of the 506 cases
(Table 3). Of these, 38 (73.1%) were active infections (20
acute infections plus 18 chronic infections) and 14
(26.9%) were past infections. Out of the histology posi-
tive samples, 38 were positive by PCR (32 active infec-
tions and six past infections). There were 11 active
infection (2.4%) and 11 (2.4%) past infections detected
by placental histology that were negative by the other
test techniques.
Among the 38 active infections identified by histology,
25 (65.8%, 95% CI 48.5-79.8) were positive by peripheralTable 3 Histopathology based placental malaria infections co
Histopathology
Infected*
Tests n/N n = 38
Any species
Any smear/RDT+, n (%) 47/505a 27/38 (71.1)
Peripheral microscopy+, n (%) 39/504b 25/38 (65.8)
Placenta impression smear+, n (%) 22/505c 17/38 (44.7)
Placental incision smear+, n (%) 32/504d 23/37 (62.1)
RDT+, n (%) 29/506 20/38 (52.6)
No infection smear/RDT, n (%) 458/505 11/38 (28.9)
PCR+, n (%) 62/110e 32/38 (84.2)
P. falciparum
Any smear/RDT+, n (%) 24/505‡ 21/38 (55.3)
Peripheral microscopy, n (%) 28/505 25/38 (65.8)
Placental impression smear, n (%) 19/505 17/38 (44.7)
Placental incision smear, n (%) 26/504 23/37 (60.5)
RDT+, n (%) 12/506 11/38 (28.9)
PCR+, n (%) 45/110f 30/38 (78.9)
P. vivax
Any smear/RDT+, n (%) 14/505‡ 0
Peripheral microscopy, n (%) 11/505 0
Placental impression smear, n (%) 3/504 0
Placental incision smear, n (%) 6/505 0
RDT+, n (%) 8/506
PCR+, n (%) 10/110f 0
Mixed infection (Pf + Pv)
RDT mixed +, n (%) 9/506 6/38 (15.8)
PCR mixed +, n (%) 7/110 2/38 (5.3)
aOut of 50 any smear/RDT positives, 3 samples were missing and were not included
bAmong 39 positive peripheral smears, 11 were incision negative, and 20 were imp
smear negative; dAmong 32 positive incision smears, 4 were peripheral smear nega
corresponding to histology positive samples and a similar number of negative sam
fIncludes mixed species; there were no mixed species infection detected on smearsmear microscopy. These included all 20 acute infections
and five of the 18 chronic infections (Table 3). All 25 in-
fections corresponded to P. falciparum and none was
due to P. vivax. None of the 14 cases with histological
evidence of a past infection had detectable P. falciparum
malaria by peripheral microscopy, but two were periph-
eral microscopy positive for P. vivax.
Incision smears identified 60.5% (95% CI 44.7-77.1) of
histological P. falciparum placental infections (Table 3).
The positive predictive value of an incision smear to de-
tect P. falciparum placental infection was 88.5% (95% CI
68.7-96.9) and the negative predictive value was 96.9%
(94.8-98.2). Impression smears correctly identified placen-
tal infection in 44.7% (28.9-61.5) of cases, with a positive
predictive value of 89.4% (65.4-98.1), and a negativempared to standard microscopy and other tests
Acute Chronic Past Non-infected
n = 20 n = 18 n = 14 n = 454
20/20 (100) 7/18 (38.9) 3/14 (21.4) 17/453 (3.7)
20/20 (100) 5/18 (27.8) 2/14 (14.3) 12/453 (2.6)
14/20 (70.0) 3/18 (16.7) 1/14 (7.1) 4/453 (0.9)
18/20 (90.0) 5/17 (29.4) 2/14 (14.3) 7/453 (1.5)
17/20 (85.0) 3/18 (16.7) 1/14 (7.1) 8/454 (1.7)
0/20 (0) 11/18 (61.1) 11/14 (78.6) 436/453 (96.2)
19/20 (95.0) 13/18 (72.2) 6/14 (54.5) 24/62 (38.7)
14/20 (70.0) 7/18 (38.9) 0 3/453 (0.6)
20/20 (100) 5/18 (17.9) 0 3/453 (0.7)
14/20 (70.0) 3/18 (15.8) 0 2/453 (0.4)
18/20 (90.0) 5/18 (19.2) 0 3/453 (0.7)
9/20 (45.0) 2/18 (11.1) 0 1/454 (0.2)
18/20 (90.0) 12/18 (66.6) 3/11 (21.4) 12/62 (19.4
0 0 3/14 (21.4) 11/453 (2.4)
0 0 2/14 (14.3) 9/453 (2.0)
0 0 1/14 (7.1) 2/453 (0.4)
0 0 2/14 (14.3) 4/453 (0.9)
2/20 (10.0) 1/18 (5.5) 1/14 (7.1) 4/454 (0.8)
0 0 3/14 (21.4) 7/62 (11.3)
6/20 (30.0) 0 0 3/454 (0.7)
1/20 (5.0) 1/18 (5.6) 0 5/62 (8.1)
in the analysis; *acute + chronic infections ‡excludes mixed RDT infections
ression negative. cAmong 22 positive impression smears, 3 were peripheral
tive; ePCR was performed for species confirmation on a sub-set of 115 samples
ples chosen for quality assurance matched by gravidity and study sites;
microscopy. Abbreviations: Plac. = placental.
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of either incision or impression smear identified 70% of
histopathologically active infections.
The distribution of parasitized erythrocytes in the
intervillous space was scanty: 60% showed <1% parasit-
aemia and 32.5% cases had parasitaemia between 1-10%.
Individual erythrocytes were rarely seen adhering to the
syncytial layer. No parasites were observed in foetal
erythrocytes or within the villous structures. Among the
active infections, monocyte presence was mostly mild
(63%) or moderate (23.6%) with only 1 case of a severe
intervillous infiltrate (2.6%) (Table 4). The geometric
mean parasite density of P. falciparum was 568 para-
sites/μL and P. vivax was 149 parasites/μL in maternalTable 4 Placental histology features by category of histopath
Placental features No† Past†† Past vs Active♣
Inf. Inf. No inf. Inf.
n = 454 n = 14 p-value n = 38
Syncytial Knots
Normal, n (%) 414 (91.2) 8 (57.1) <0.001 18 (47.4)
Increased (>1/3), n(%) 40 (8.8) 6 (42.9) 20 (52.6)
Fibrinoid necrosis
Absent, n (%) 393 (86.5) 7 (50.0) 27 (71.1)
Focal, n (%) 58 (12.8) 6 (42.9) 0.0001 9 (23.6)
Diffuse, n (%) 3 (0.7) 1 (7.1) 2 (5.3)
Calcification
Absent, n (%) 416 (91.6) 9 (64.3) 29 (76.3)
Focal, n (%) 31 (6.8) 4 (28.6) 0.002 7 (18.4)
Diffuse, n (%) 7 (1.6) 1 (7.1) 2 (5.3)
IVS* PMN cell
Absent, n (%) 340 (74.9) 13 (92.9) 26 (70.3)
Mild, n (%) 80 (17.6) 1 (7.1) 0.47 9 (24.3)
Moderate, n (%) 33 (7.3) 0 2 (5.4)
Severe, n (%) 1 (0.2) 0 0
IVS* monocyte
Absent, n (%) 358 (78.8) 11 (78.6) 3 (7.9)
Mild, n (%) 74 (16.3) 3 (21.4) 0.63 24 (63.2)
Moderate, n (%) 22 (4.9) 0 10 (26.3)
Severe, n (%) 0 0 1 (2.6)
IVS* fibrin
Absent, n (%) 134 (29.5) 0 4 (10.5)
Mild, n (%) 268 (59.0) 5 (35.7) <0.001 25 (65.8)
Moderate, n (%) 52 (11.5) 9 (64.3) 8 (21.1)
Severe, n (%) 0 0 1 (2.6)
All are column %. Active infection group includes 1 missing result for IVS PMN cell
Acute infection = parasite present, ±pigmented monocytes, ± few spots pigment in
in fibrin; Active infection = acute + chronic infection; Past infection = no parasites, on
♣pooled histology classified acute & chronic infection. Abbreviations: *IVS = intervilloblood samples corresponding to the placental histology
samples (not shown in the table).
Histopathological changes associated with malaria
Active and past infections were associated with an in-
creased frequency of syncytial knotting, focal fibrinoid
necrosis, focal calcification and fibrin deposits in the
intervillous space (Table 4). Signs of severe infection or
inflammation were not observed. The placental histo-
logical features corresponding to PCR confirmed periph-
eral blood mono-infections of P. falciparum (n = 28) or
P. vivax (n = 11) are presented in Table 5. Plasmodium
falciparum mono-infections were more likely to be asso-
ciated with mild to moderate infiltration of intervillousological infection (independent of Plasmodium species)
Active vs
No inf.
Acute
Inf.
Acute vs
No inf.
Chronic
Inf.
Chronic vs
No inf.
p value n = 20 p value n = 18 p value
<0.0001 12 (60.0) 0.0003 6 (33.3) <0.0001
8 (40.0) 12 (66.7)
20 (100.0) 7 (38.9)
0.003 0 0.15 9 (50.0) <0.0001
0 2 (11.1)
20 (100.0) 9 (50.0)
0.008 0 0.30 7 (38.9) <0.0001
0 2 (11.1)
14 (70.0) 12 (70.6)
0.75 4 (20.0) 0.93 5 (29.4) 0.45
2 (10.0) 0
0 0
1 (5.0) 2 (11.1)
<0.0001 12 (60.0) <0.0001 12 (66.7) <0.0001
6 (30.0) 4 (22.2)
1 (5.0) 0
4 (20.0) 0
0.0002 15 (75.0) <0.47 10 (55.6) <0.0001
1 (5.0) 7 (38.9)
0 1 (5.5)
score. †histology classification. No-infection = parasite and pigment absent,
fibrin; Chronic infection = parasite present, ±pigmented monocytes, +pigment
ly pigment present; ††includes 2 cases corresponding to P. vivax infection;
us space; PMN = polymorphonuclear.
Table 5 Placental histology features in peripherally patent P. falciparum and P. vivax cases
Placental feature No† infection Pf Pv Pf vs no infection Pv vs no Infection Pf vs Pv
n = 441 n =28 n = 11 P value P value P value
Syncytial Knots
Normal, n (%) 406 (92.1) 16 (57.1) 4 (36.4) <0.0001 <0.0001 0.03
Increased (>1/3), n (%) 35 (7.9) 12 (42.9) 7 (63.6)
Fibrinoid necrosis
Absent, n (%) 380 (86.2) 24 (85.7) 9 (81.8)
Focal, n (%) 58 (13.2) 3 (10.7) 2 (18.2) 0.25 0.85 0.68
Diffuse, n (%) 3 (0.6) 1 (3.6) 0
Intravillous calcification
Absent, n (%) 403 (91.4) 25 (89.3) 11 (100.0)
Focal, n (%) 31 (7.0) 2 (7.1) 0 0.73 0.59 0.52
Diffuse, n (%) 7 (1.6) 1 (3.6) 0
Intervillous fibrin
Absent, n (%) 125 (28.3) 6 (21.4) 7 (63.6)
Mild, n (%) 265 (60.1) 20 (71.4) 4 (36.4) 0.48 0.03 0.03
Moderate, n (%) 51 (11.6) 2 (7.2) 0
Severe, n (%) 0 0 0
IVS polymorphonuclear cells
Absent, n (%) 335 (75.9) 19 (70.4) 3 (27.3)
Mild, n (%) 77 (17.5) 6 (22.2) 3 (27.3) 0.91 <0.0001 0.01
Moderate, n (%) 28 (6.4) 2 (7.4) 5 (45.4)
Severe, n (%) 1 (0.2) 0 0
Intervillous monocytes
Absent, n (%) 351 (79.6) 4 (14.3) 5 (45.5)
Mild, n (%) 69 (15.7) 13 (46.4) 5 (45.5) <0.0001 0.02 0.12
Moderate, n (%) 21 (4.7) 10 (35.7) 1 (9.0)
Severe, n (%) 0 1 (3.6) 0
All are column %; †negative for parasites by smear microscopy & histology. Abbreviations: Pf = P. falciparum, Pv = P. vivax; IVS = intervillous space.
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infection, whereas P. vivax infections were associated
with increased syncytial knots and moderate poly-
morphonuclear cell infiltration.
Impact of histological changes (Plasmodium falciparum)
on maternal morbidity and delivery outcome
Among the 506 cases examined for histopathology, there
were 22 stillbirths. Four stillbirths occurred in women
with an active infection based on histology (4/38 = 10.5%),
which was significantly higher than in uninfected women
(RR 3.8, 95% CI 1.2-12.1). Three of the four had parasit-
aemia <1% (where placental microscopy identified 1–5
parasites per high power field), and one infection was clas-
sified as severe. Chronic infections were not associated
with an increase in stillbirth (RR 1.3, 95% CI 0.17-9.1).
Overall, 21.5% of women had fever (temperature ≥
37.5°C) at the time of delivery or history of fever in theprevious week. Fever on the day of delivery was not as-
sociated with active placental infections (RR 0.8, 95% CI
0.27-2.6) whereas relative risk of an active placental in-
fection was 2.5 (95% CI 1.5-4.0) in women with history
of fever in the past week. Fever was not associated with
stillbirth however; fever occurred in 27.3% [6/22] of
women with a stillbirth, and 20.7% [98/473] of women
with a live birth, RR 1.3, 95% CI 0.65-2.6).
There were 482 singleton live births. The presence of
parasites or pigmented monocytes was associated with
decreased birth weight, gestational age at birth and ma-
ternal haemoglobin levels in univariate analysis (Table 6).
In addition, increased syncytial knotting or focal calcifi-
cation was associated with a shorter duration of pregnancy.
Multivariate models showed that only the acute P. falcip-
arum infections were associated with reductions in birth
weight (400 g, 95% CI 113–687) or mean gestational age
(0.8 weeks, 95% CI 0.04-1.6) or lower haemoglobin levels
Table 6 Univariate analysis of placental Plasmodium falciparum histological determinants of birth weight, gestational
age and maternal haemoglobin
Birth weight (BW) Gestational age (GA) Maternal haemoglobin (Hb)
Factors N Mean
BW (SD)
Mean
difference
(95% CI)
p Mean
GA (SD)
Mean
difference
(95% CI)
p N Mean
Hb (SD)
Mean
difference
(95% CI)
p
Placental parasites
Present 33 2419 (535) −217 (−375, −58) 0.01 36.7 (1.2) −0.5 (−1.03, −0.11) 0.01 38 9.6 (2.4) −0.9 (−1.63, −0.17) 0.02
Absent 441 2636 (440) Reference 37.3 (1.3) Reference 464 10.5 (2.1) Reference
Syncytial knots
Increased 59 2546 (501) −85 (−208, 37) 0.2 36.8 (1.6) −0.5 (−0.81, −0.1) 0.01 65 10.3 (2.6) −0.2 (−0.79, 0.35) 0.4
Normal 415 2631 (442) Reference 37.3 (1.2) Reference 437 10.5 (2.1) Reference
Fibrinoid necrosis
Present 75 2620 (476) −1 (−112, 110) 0.9 37.0 (1.4) −0.3 (−0.58,0.05) 0.1 78 10.6 (2.2) 0.2 (−0.32, 0.76) 0.4
Absent 399 2621 (446) Reference 37.3 (1.3) Reference 424 10.4 (2.2) Reference
Intervillous fibrin
Moderate-severe 68 2616 (432) −18 (−178, 141) 37.1 (1.5) −0.1 (−0.5, 0.4) 68 10.2 (1.8) −0.6 (−1.34, 0.18) 0.1
Mild 281 2616 (470) −18 (−133, 95) 0.8 37.2 (1.3) 0.0 (−0.3, 0.3) 0.8 295 10.4 (2.3) −0.4 (−0.90, 0.16)
Absent 125 2634 (417) Reference 37.2 (1.2) Reference 139 10.8 (2.1) Reference
Calcification
Focal 51 2519 (426) −114 (−245, 16) 0.1 36.8 (1.3) −0.5 (− 0.87, −0.11) 0.01 51 10.2 (2.8) −0.3 (−1.03, 0.24) 0.2
Absent 423 2633 (452) Reference 37.3 (1.3) Reference 451 10.5 (2.1) Reference
Pigmented fibrin
Present 36 2527 (452) −101 (−254, 52) 0.2 37.0 (1.2) −0.3 (−0.72, 0.16) 0.2 40 10.2 (2.1) −0.3 (−0.98, 0.44) 0.4
Absent 438 2628 (450) Reference 37.3 (1.3) Reference 462 10.5 (2.2) Reference
Pigmented monocytes
Present 16 2257 (516) −376 (−598, −153) 0.001 36.5 (1.2) −0.7 (−1.37, −0.07) 0.02 19 9.1 (2.7) −1.4 (−2.4, −0.4) 0.01
Absent 458 2633 (443) Reference 37.3 (1.3) Reference 483 10.5 (2.1) Reference
*IVS Polymorponuclear
cells
Moderate-severe 33 2594 (422) −22 (−215, 172) 37.5 (1.1) 0.3 (−0.22, −0.89) 36 10.8 (2.5) 0.3 (−0.54, 1.26) 0.5
Mild 84 2647 (436) 31 (−98, 159) 0.8 37.3 (1.3) 0.1 (−0.21,0.53) 0.2 90 10.4 (2.3) −0.1 (−0.70, 0.51)
Absent 356 2616 (458) Reference 37.2 (1.3) Reference 376 10.5 (2.1) Reference
*IVS Monocytes
Moderate-severe 30 2634 (515) −1 (−202, 200) 37.4 (1.6) 0.2 (−0.42,0.74) 33 9.7 (2.7) −0.8 (−1.79, 0.08)
Mild 95 2563 (454) −72 (−195, 50) 0.4 37.1 (1.2) −0.1 (−0.46, 0.25) 0.6 101 10.5 (2.4) −0 .1 (−0.65, 0.51) 0.1
Absent 349 2635 (444) Reference 37.2 (1.3) Reference 368 10.6 (2.1) Reference
Abbreviations: SD = standard deviation; CI = confidence interval; *IVS = intervillous space; BW = Birth weight; GA = gestational age
Note: BW and GA were assessed for singleton live-birth babies only. Among 506 cases assessed, BW and GA were not available for 23 stillbirths, 1 twin delivery,
and 8 newborn babies who needed immediate medical attention at birth. Maternal haemoglobin was missing in 4 of the 506 cases.
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Further analysis showed an interaction between the effects
of pigmented monocytes and parasites. The greatest effect
on birth weight, gestational age and haemoglobin were ob-
served among women who had both parasites and pigmen-
ted monocytes, whereas the effect of the presence of
parasites only (n = 17) or of pigmented monocytes only
(n = 14) was smaller and not statistically significant
(Table 7). Further stratification showed that the reductionof birth weight was greatest in women with moderate-to-
severe infiltrates of pigmented monocytes, as opposed to
mild levels of infiltration (Table 7).
Histopathology did not identify any active P. vivax in-
fections. The presence of peripheral P. vivax infection
(11 cases) was not associated with significant reductions
in birth weight (2561 g [SD 200] [P. vivax, n = 11] vs.
2639 gr [SD 445] [no P. falciparum or P. vivax malaria,
N = 445], mean difference: −78 g, 95% CI −225.2 to
Table 7 Association of placental falciparum histologically-confirmed infection and birth weight, gestational age and
maternal haemoglobin – multivariate analysis
Adjusted birth weight Adjusted gestational age Adjusted maternal haemoglobin
Factors N Mean (SD) Mean
difference
(95% CI)
P Mean
GA (SD)
Mean
difference
(95% CI)
P N Mean
Hb (SD)
Mean
difference
(95% CI)
P
1. Infection based on
histopathology [3]
Acute 16 2232 (541) −400 (−687, −113) 0.001 36.5 (1.3) −0.8 (−1.6,-0.04) 0.06 20 8.8 (2.4) −1.4 (−2.4,-0.5) 0.02
Chronic 17 2594 (481) −38 (−316, 240) 37.0 (1.2) −0.3 (−1.2, 0.45) 18 10.6 (2.2) 0.1(−0.8, 1.1)
Past 12 2820 (518) 188 (−141, 517) 37.3 (1.1) 0.0 (−0.9, 1.0) 11 10.4 (2.1) −0.1(−1.5,1.0)
No infection 419 2632 (442) Reference 37.3 (1.3) Reference 442 10.5 (2.1) Reference
2. Placental infection
based on
Para + p monoc 16 2274 (516) −356 (−580, −132) 0.01 36.6 (1.2) −0.6 (−1.3, 0.02) 0.04 19 9.3 (2.7) −1.1 (−2.1, −0.1) 0.016
Parasites only 17 2588 (523) −42 (−257, 173) 36.7 (1.3) −0.5 (−1.2, 0.07) 19 10.2 (2.1) −0.2 (−1.2, 0.8)
No infection 431 2630 (444) Reference 37.3 (1.3) Reference 453 10.4 (2.2) Reference
3. Placental infection
based on
Para + ms p monoc 3 2031 (582) −600 (−1108,-92) 0.01 36.2 (1.0) −1.1 (−2.6, 0.3) 0.05 4 9.1 (1.5) −1.4 (−3.4, 0.8) 0.041
Para + mi p monoc 13 2329 (507) −302 (−547, −56) 36.7 (1.2) −0.6 (−1.2, 0.2) 15 9.2 (2.9) −1.3 (−2.2, 0.1)
Parasites only 17 2588 (523) - 43 (−258,173) 36.7 (1.4) −0.6 (−1.2, 0.1) 19 10.2 (2.2) −0.3 (−1.2, 0.7)
No infection 431 2631 (444) Reference 37.3 (1.3) Reference 453 10.5 (2.2) Reference
4. Sub-patent infections*
Para + p monoc 3 2446 (490) −177 (−616, 263) 0.4 37.0 (0.8) −0.3 (−1.6, 0.9) 0.8 4 10.4 (4.1) −0.1 (−2.1, 2.1) 0.9
Parasites only 8 2778 (430) 155 (−151, 461) 37.2 (1.4) −0.1 (−1.0, 0.8) 8 10.7 (1.5) −0.2 (−1.1, 1.6)
No infection 431 2623 (444) Reference 37.3 (1.3) Reference 453 10.5 (2.1) Reference
SD = standard deviation; CI = confidence interval; P = p-value; para = parasite; p = pigmented; mi = mild; ms =moderate to severe; monoc =monocytes. All models
adjusted for socioeconomic status, gravidity, education, residence. *Model 4 = histology positive, among those negative by any of the standard
microscopy/RDT methods.
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to 0.5) or maternal haemoglobin (−0.4 g/dL, 95% CI −1.6
to 0.9).
Sub-patent placental infections (any smear or RDT
negative, histology positive)
In the 12 women who were slide smear and peripheral
RDT negative but who had parasites detected by hist-
ology (sub-patent infection), the mean birth weight, ges-
tational age and maternal haemoglobin levels were lower
if both parasites and pigmented monocytes were de-
tected, but numbers were small and the difference was
not statistically significant (Table 7).
Discussion
Few studies have described placental malaria associated
histopathology outside sub-Saharan Africa. Histological
changes associated with P. falciparum and P. vivax in-
fections and the corresponding impact on adverse birth
outcome and maternal anaemia were assessed in an area
of low malaria transmission in central India. This was a
pregnant population at low risk of malaria and despitethe low parasitaemia seen by the low maternal blood
geometric mean parasite density and placental parasite
percentage, the impact of infection was considerable and
independent of the presence of documented of fever.
Based on placental incision microscopy, the overall
prevalence of malaria at delivery was 1.0%, and compar-
able to recent studies in other regions in India [31,32].
As expected, placental histology was more sensitive to
detect P. falciparum malaria than placental or peripheral
smear microscopy alone. Approximately one in 40 women
(2.4%) that were negative by conventional microscopy (ei-
ther placental or peripheral) or pLDH-based RDT were
found to have active placental P. falciparum infections
(acute or chronic) by histology. When this estimate of
‘subpatent’ infections was extrapolated to the overall sur-
vey sample of 2282 women, the prevalence of P. falcip-
arum placental malaria increased from 2.2% (50/2282) to
4.5%, doubling the estimate. Placental incision microscopy
alone missed about two out of every three infections
which could be explained by the largely low parasitaemia.
Women with subpatent infections had lower maternal
haemoglobin, mean birth weight and gestational age,
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cance, likely because of the small number of women with
submicroscopic infections.
Most (89.3%, 25/28) of the women with patent mater-
nal blood P. falciparum infections detected by con-
ventional microscopy also had evidence of an active
placental histopathology infection. In contrast, no pla-
cental parasites could be detected by histology among
the 11 women with patent peripheral P. vivax infections
and none of the women who were smear negative for
peripheral P. vivax had evidence of infection with histo-
pathology. This highlights the importance of using sensi-
tive methods such as placental histology or PCR to
detect placental P. falciparum infection as conventional
peripheral and placental microscopy smear results alone
may markedly underestimate the true burden of P. fal-
ciparum malaria in this region.
Histopathology is a useful method to grade the chron-
ology of placental P. falciparum infections [3,4]. Com-
pared to observations in areas of high transmission, a
relatively large proportion (38%) of histopathological in-
fections with P. falciparum were acute rather than
chronic or past infections. This might be explained by
the low malaria exposure and low host immunity in this
population triggering an inflammatory response and
early delivery when the placenta becomes infected, al-
though the adverse impact of infection was independent
of the occurrence of fever in this study. The low expos-
ure is also reflected by the low parasitaemia within the
placenta and the corresponding mild inflammatory re-
sponse. This contrasts with the dense parasitaemia and
the occasionally massive chronic intervillositis and mono-
cyte infiltration reported from highly endemic areas in
sub-Saharan Africa [9], but is similar to observations
from the Thai-Burmese border [10] and Colombia
[16-18]. Similar to previous reports, most parasites were
found in the intervillous space without adhering to the
syncytial layer and none were observed within the villous
structure [4,10,33].
Chronic P. falciparum infection was associated with
an increase in syncytial knots, focal fibrinoid necrosis
and calcification. These changes were also evident in
past infections, suggesting they persist after parasites are
cleared [4]. Alternatively, there might have been insuffi-
cient time for their resolution since time between infec-
tion and delivery might have been short, similar to
observations on the Thai-Burmese border [10].
Placental P. falciparum malaria was associated with
maternal anaemia. Acute infection was associated with
lower levels of mean haemoglobin (1.4 g/dL), compar-
able to observations in a study from Malawi [7]. Chronic
infections were not associated with lower haemoglobin
level. The proportion of low birth weight in this popula-
tion is high and is consistent with previous reports fromIndia [34,35]. Adding to it, the impact of placental P. fal-
ciparum infection on birth weight was considerable, des-
pite the scarcity of parasites within the placenta and the
mild degree of placental inflammation. Of all the histo-
logical measures, only the presence of parasites and
pigmented monocytic infiltration were consistently asso-
ciated with reduced birth weight and shorter gestation
in multivariate analysis. Further analysis showed that the
effect on birth weight and gestation was particularly evi-
dent among the active infections with pigmented mono-
cyte infiltration, a reduction in birth weight of 356
grams compared to 42 grams in women with presence
of parasites alone, especially if this monocyte infiltration
was moderate to severe. While mononuclear cells as a
source of inflammatory cytokines have been suggested
to have a role in poor foetal growth [11,36] [37-39] the
infection level of 1–5 parasites per 100x magnification
field approximating to <1% parasitaemia in 60% of cases
in this study also suggests that mechanisms other than
the presence of placental parasitaemia per se may play a
role.
The observed shortening of the duration of pregnancy
with active infections was an important contributor to
the reduction in birth weight. It is possible that with the
increased risk of acute infections in women with history
of fever, the inflammatory response to infections might
induce early labour. Thus infections may not last to lead
to chronicity. Alternatively clinical symptoms may lead
women to seek treatment and prevent chronicity. The
average duration of pregnancy was 4 days shorter among
women with an active infection and mild monocyte infil-
tration, and 8 days shorter in women with moderate to
severe infiltration. Although this may appear a relatively
small difference, the average increase in birth weight be-
tween 37 to 40 weeks gestation is estimated at 169
grams per week [40]. Additionally, chronic or past infec-
tions were not associated with low birth weight or
shorter gestation, which supports the notion that malaria
associated low birth weight results, at least in part, from
a shortening of gestation triggered by acute infections in
women with low protective immunity [4,7,9,41].
There was no evidence of P. vivax sequestration in the
placenta. Pigment in the fibrin was observed in two per-
ipherally patent P. vivax cases, which is consistent with
reports from Thailand and Peru [10,24], although previ-
ous infections with P. falciparum cannot be excluded.
Recent studies on immune aspect of placental malaria in
Colombia indicate a possible pathogenic role of P. vivax
[16,18] A noteworthy observation in Plasmodium vivax
cases was the significantly higher presence of poly-
morphonuclear leukocytes and syncytial knots compared
to P. falciparum infected placentas, suggesting a possible
placental inflammatory response that might be different
from that observed with P. falciparum. In addition,
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falciparum or uninfected placentas. There was no as-
sociation, however, between polymorphonuclear cells
or increased syncytial knots and birth weight or pre-
term births, although numbers may have been too
small.
The study was limited by its cross-sectional design,
which did not allow assessing the impact of earlier preg-
nancy infections via peripheral microscopy. If such
infections resolve and are no longer evident as ‘past’ in-
fections but still impact on maternal anaemia and birth
outcome, the burden of malaria may have been underes-
timated. The number of women with P. vivax mono-
infections was too low to draw firm conclusions. Al-
though a single reader examined the sections and she
was not blinded to the peripheral, placental microscopy
and RDT results, a random sample of positive slides and
those corresponding to patent P. vivax cases were
reviewed blinded by a senior placental histopathologist
in the US and confirmed the accuracy of the results of
the first reading. PCR conducted in a subset of samples,
provided further confirmation of species and the accuracy
of the histological examination. The Ballard score that was
used has not been validated in India. It was beyond the
scope of this study to assess conditions other than malaria
that may affect birth weight, haemoglobin level and pre-
maturity (e.g. iron deficiency, other infections).Conclusions
Severe placental inflammation associated with P. falcip-
arum infection proved rare in this population. Despite
this, a substantial impact of P. falciparum placental in-
fections on birth weight was observed, which in part
could be explained by shortening in the average duration
of pregnancy. There was no evidence of P. vivax seques-
tration in the placenta and any histological changes ob-
served were mild, however the number of P. vivax
infections were small. These findings with P. falciparum
infections highlight the need for early (including subpa-
tent) case-detection and the challenge of malaria control
during pregnancy in areas of low malaria transmission
to reduce the detrimental impact of malaria during preg-
nancy in this region.Competing interests
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